Ftse Mib
34.230,34
-0,42%
DAX
18.487,73
-0,60%
S&P 500
5.631,22
0,28%
NASDAQ
0,00
0,00%
Bitcoin
63.666,23
-1,83%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ AbCellera Biologics Inc (ABCL) AbCellera Biologics Inc (ABCL) Notizie

ABCL

AbCellera Biologics (ABCL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL
DataOraFonteTitoloSimboloCompagnia
23/02/202402:15Business WireAbCellera to Present at Upcoming Investor Conferences in MarchNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ABCLAbCellera Biologics Inc
20/02/202422:05Business WireAbCellera Reports Full Year 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
23/01/202422:05Business WireAbCellera to Report Full Year 2023 Financial Results on February 20, 2024NASDAQ:ABCLAbCellera Biologics Inc
17/01/202400:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ABCLAbCellera Biologics Inc
20/12/202322:05Business WireAbCellera to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 10, 2024NASDAQ:ABCLAbCellera Biologics Inc
16/11/202322:05Business WireAbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023NASDAQ:ABCLAbCellera Biologics Inc
03/11/202317:05Business WireAbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023NASDAQ:ABCLAbCellera Biologics Inc
02/11/202321:05Business WireAbCellera Reports Q3 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
01/11/202321:05GlobeNewswire Inc.Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in OncologyNASDAQ:ABCLAbCellera Biologics Inc
31/10/202321:05Business WireAbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023NASDAQ:ABCLAbCellera Biologics Inc
11/10/202322:05Business WireAbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023NASDAQ:ABCLAbCellera Biologics Inc
27/09/202315:00Business WireAbCellera Announces Two T-Cell Engager Presentations at SITC 2023NASDAQ:ABCLAbCellera Biologics Inc
20/09/202323:02Business WireAbCellera Expands Multi-Target Antibody Discovery Collaboration with RegeneronNASDAQ:ABCLAbCellera Biologics Inc
13/09/202315:00Business WireAbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in OncologyNASDAQ:ABCLAbCellera Biologics Inc
03/08/202322:33Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ABCLAbCellera Biologics Inc
03/08/202322:05Business WireAbCellera Reports Q2 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
24/07/202322:05Business WireAbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for RehearingNASDAQ:ABCLAbCellera Biologics Inc
06/07/202322:05Business WireAbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023NASDAQ:ABCLAbCellera Biologics Inc
30/05/202319:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ABCLAbCellera Biologics Inc
29/05/202322:05Business WireAbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023NASDAQ:ABCLAbCellera Biologics Inc
24/05/202319:10Business WireAbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to PatientsNASDAQ:ABCLAbCellera Biologics Inc
04/05/202323:01Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ABCLAbCellera Biologics Inc
04/05/202322:41Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ABCLAbCellera Biologics Inc
04/05/202322:05Business WireAbCellera Reports Q1 2023 Business ResultsNASDAQ:ABCLAbCellera Biologics Inc
28/04/202323:02Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:ABCLAbCellera Biologics Inc
17/04/202315:10Business WireAbCellera Presents New Data on T-Cell Engager Platform at AACR 2023NASDAQ:ABCLAbCellera Biologics Inc
11/04/202322:05Business WireAbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023NASDAQ:ABCLAbCellera Biologics Inc
06/04/202322:05Business WireAbCellera to Report First Quarter 2023 Financial Results on May 4, 2023NASDAQ:ABCLAbCellera Biologics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ABCL

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENEL
Enel
BIT
FBK
Finecobank
BIT
STLAM
Stellantis NV
BIT
RACE
Ferrari NV
BIT
ENI
Eni
BIT
BC
Brunello Cucinelli
BIT
PRY
Prysmian
BIT
G
Generali
BIT
SPM
Saipem
BIT
MONC
Moncler
BIT
LDO
Leonardo
BIT
STMMI
ST Microelectronics
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BPE
Bper Banca
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network